RDNT vs SHC

RDNT exhibits severe fundamental weakness, highlighted by a Piotroski F-Score of 2/9, indicating poor financial health and deteriorating operational efficiency. While revenue growth remains positive at 14.8%, the company is struggling with negative profit margins (-0.91%) and a catastrophic collapse in year-over-year EPS growth (-104.5%). There is a stark divergence between the 'Strong Buy' analyst consensus and the bearish reality of insider selling and negative earnings surprises. The valuation is aggressive, with a forward P/E of 58.82 that is not supported by current profitability.

SHC presents a conflicted profile with a stable Piotroski F-Score of 4/9 but significant valuation gaps, as the current price of $16.30 far exceeds the Graham Number ($3.6) and Intrinsic Value ($7.97). While the company shows explosive earnings growth (175.4% YoY) and strong operating margins, these are offset by a high Debt/Equity ratio of 3.76 and a bearish technical trend. The stark contrast between bullish analyst targets ($20.50) and aggressive insider selling ($1.28B) suggests a high-risk environment where growth expectations are priced in at a steep premium.